Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1809472rdf:typepubmed:Citationlld:pubmed
pubmed-article:1809472lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:1809472lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:1809472lifeskim:mentionsumls-concept:C0003448lld:lifeskim
pubmed-article:1809472pubmed:issue10lld:pubmed
pubmed-article:1809472pubmed:dateCreated1992-5-26lld:pubmed
pubmed-article:1809472pubmed:abstractTextAfter kidney transplantation 1-3.6% of patients develop tuberculosis. At early diagnosis and addressly applied treatment the disease is not life threatening. On the basis of the author's own experience and literary data, suitable combinations of antituberculotics are recommended. At normal or reduced function of the kidney transplant a combination of isoniazid, rifampicin, and pyrazinamide is advocated. In deranged liver function the combination of choice consists of isoniazid, streptomycin, and ethambutol. (Ref. 9).lld:pubmed
pubmed-article:1809472pubmed:languageczelld:pubmed
pubmed-article:1809472pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1809472pubmed:citationSubsetIMlld:pubmed
pubmed-article:1809472pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1809472pubmed:statusMEDLINElld:pubmed
pubmed-article:1809472pubmed:monthOctlld:pubmed
pubmed-article:1809472pubmed:issn0006-9248lld:pubmed
pubmed-article:1809472pubmed:authorpubmed-author:NouzaMMlld:pubmed
pubmed-article:1809472pubmed:issnTypePrintlld:pubmed
pubmed-article:1809472pubmed:volume92lld:pubmed
pubmed-article:1809472pubmed:ownerNLMlld:pubmed
pubmed-article:1809472pubmed:authorsCompleteYlld:pubmed
pubmed-article:1809472pubmed:pagination510-1lld:pubmed
pubmed-article:1809472pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:1809472pubmed:meshHeadingpubmed-meshheading:1809472-...lld:pubmed
pubmed-article:1809472pubmed:meshHeadingpubmed-meshheading:1809472-...lld:pubmed
pubmed-article:1809472pubmed:meshHeadingpubmed-meshheading:1809472-...lld:pubmed
pubmed-article:1809472pubmed:meshHeadingpubmed-meshheading:1809472-...lld:pubmed
pubmed-article:1809472pubmed:meshHeadingpubmed-meshheading:1809472-...lld:pubmed
pubmed-article:1809472pubmed:year1991lld:pubmed
pubmed-article:1809472pubmed:articleTitle[Treatment with antitubercular agents after kidney transplantation].lld:pubmed
pubmed-article:1809472pubmed:affiliationIII. interní výzkumná základna Institutu klinické a experimentální mediciny v Praze-Krci.lld:pubmed
pubmed-article:1809472pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1809472pubmed:publicationTypeEnglish Abstractlld:pubmed